Repligen CorpRGEN
Price (close)
$190.65
Market cap
$10.8B
P/E
259.0x
Revenue (TTM)
$785.1M
Net income
$41.5M
Dividend yield
—
1-year total return
56.7%
Net margin
5.3%
Revenue growth
16.5%
Debt / equity
0.26x
What Repligen Corp does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $366.3M | $670.5M | $801.5M | $632.4M | $634.4M | $738.3M |
| Net income | $59.9M | $128.3M | $186.0M | $35.6M | -$25.5M | $48.9M |
| Free cash flow | $40.2M | $51.9M | $87.2M | $77.7M | $149.7M | $93.9M |
More on RGEN.
- Repligen Corp summary
- Repligen Corp financial statements
- Repligen Corp key metrics
- Repligen Corp health scores and style box
- Repligen Corp earnings
- Repligen Corp dividends
- Repligen Corp valuation
- Repligen Corp ownership and insiders
- Repligen Corp peers
Figures from Repligen Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.